Showing results (241-250 of 279) with videos related to
Sort By:
Pageof 28
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 10, 2004
PET-based radiation dosimetry in man of 18F-fluorodihydrotestosterone, a new radiotracer for imaging prostate cancerPat B Zanzonico, Ronald Finn, Keith S Pentlow, et al.Sports Medicine - Open|June 12, 2026
Pulse Rate Variability Is Not the Same as Heart Rate Variability: Implications for Sports Performance and Injury PreventionKfir Ben-David, Allen B Kantrowitz, Michael Morris, et al.Urologic Oncology|August 6, 2011
A non-comparative randomized phase II study of 2 doses of ATN-224, a copper/zinc superoxide dismutase inhibitor, in patients with biochemically recurrent hormone-naïve prostate cancerJianqing Lin, Marianna Zahurak, Tomasz M Beer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2012
Randomized, double-blind, placebo-controlled phase III trial comparing docetaxel and prednisone with or without bevacizumab in men with metastatic castration-resistant prostate cancer: CALGB 90401William Kevin Kelly, Susan Halabi, Michael Carducci, et al.Health Physics|February 25, 2014
Radiation safety considerations for the use of ²²³RaCl₂ DE in men with castration-resistant prostate cancerLawrence T Dauer, Matthew J Williamson, John Humm, et al.Annals of Surgery|May 16, 2013
Burn injury enhances bone formation in heterotopic ossification modelJonathan R Peterson, Sara De La Rosa, Hongli Sun, et al.Pharmaceutical Research|March 20, 2014
Biorelevant in vitro performance testing of orally administered dosage forms-workshop reportChristos Reppas, Horst-Dieter Friedel, Amy R Barker, et al.Blood Advances|June 17, 2024
Safety and feasibility of third-party cytotoxic T lymphocytes for high-risk patients with COVID-19Dolores Grosso, John L Wagner, Allyson O'Connor, et al.Journal of Pharmaceutical Sciences|August 28, 2018
FIP Guidelines for Dissolution Testing of Solid Oral ProductsHorst Dieter Friedel, Cynthia K Brown, Amy R Barker, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 30, 2013
Phase II study of Lutetium-177-labeled anti-prostate-specific membrane antigen monoclonal antibody J591 for metastatic castration-resistant prostate cancerScott T Tagawa, Matthew I Milowsky, Michael Morris, et al.Pageof 28